WA researchers contribute to rare disease biomarker discovery
Recently published research on a rare autoimmune disorder that shares symptoms with multiple sclerosis (MS) has provided the first potential...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Perron Institute’s Media Centre displays media statements and is the central point of contact for journalists and media outlets seeking expert comments, information about research developments and other information.
All media enquiries should be directed to Perron Institute’s Communications Manager Tennille Kroemer on +61 426 044 223 or tennille.kroemer@perron.uwa.edu.au.
This contact information is for media outlets, journalists and producers only. For all other enquiries, visit the Perron Institute contact page.
Recently published research on a rare autoimmune disorder that shares symptoms with multiple sclerosis (MS) has provided the first potential...
The initial development of a novel drug treatment for children living with rare genetic diseases including Angelman syndrome has been...
An international Commission by The Lancet Neurology in collaboration with the World Stroke Organisation (WSO) and the World Health Organisation to understand...
A study evaluating the costs and benefits of involving local communities in end-of-life care found a public health approach has...
Medical Research provides an excellent return on investment in Western Australia A landmark report by Deloitte Access Economics has revealed...
A new project to improve the mental health of children and young people has been boosted by a grant to...
A Western Australian developed potential therapy ARG-007, designed to reduce brain tissue death after brain injury and other neurological conditions,...
Champion open water and marathon swimmer Andrew (Andy) Donaldson will be supporting research to improve outcomes for youth mental health...
The Perron Institute’s capability in neurosciences has been further strengthened by the appointment of John Curtin Distinguished Professor John Mamo...
An engaging roadshow will bring neuroscience education to schools and the community in regional Western Australia. The program includes public...
Biotechnology company Argenica Therapeutics, which is developing novel treatments to reduce brain tissue death following types of brain injury such...
A trailblazing neuroprotective drug developed in Western Australia to reduce brain tissue death after stroke is proceeding to the next...
Stay up to date with our latest news and announcements.